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Knowledge of the rates of antibody synthesis  throughout the immune re- 
sponse  is  of great importance  in  the  evaluation  of  the  various  factors con- 
tributing  to antibody production. Estimations of these rates have been pre- 
viously possible in systems in which precise day to day measurement of circulating 
antibody was carried out. However, such estimations, even when taking into 
account the half-life of antibody molecules (1-3) cannot approach the accuracy 
and  reliability  of  direct  measurements.  Tracer  studies  employing  labelled 
amino acids offer a means of determining rates of antibody synthesis directly, 
and recently two such studies have been  reported (4, 5). These two reports, 
which dealt with the early phases of antibody synthesis in the secondary re- 
sponse, were in disagreement concerning the amount of antibody formed during 
the first 3 days after injection of antigen. 
In the present investigation, we have obtained data concerning rates of anti- 
body  synthesis  throughout  the  first,  second,  and  hyperimmune  responses 
with special emphasis on the rate of decline of antibody production. Bovine 
gamma globulin was chosen as the antigen because there are available exten- 
sive, albeit conflicting, observations of its fate in rabbits.  It was hoped that 
knowledge of the rates of antibody synthesis might throw light on this area of 
disagreement. 
EXPEI~  I]Vf~NTA  L  PROCEDURE 
Use was made of the fact that amino acids are incorporated into proteins or catab- 
olized and/or excreted within a few hours after their injection into animals.  In rab- 
bits virtually all of the initial incorporation of injected S35-1abelled amino  acids into 
proteins occurs  within  12  hours  (6).  We have observed  that within 7 hours after 
injection more than 90 per cent of the original  free S35-1abelled amino acid  is lost 
from the serum.  Proteins once labelled  by incorporation of S  ~6 amino acids  appear 
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to retain their label until they are degraded (5). Following degradation of S35-1abelled 
protein the  S  86 amino acid may either be catabolized or  become available for re- 
incorporation into another protein. 
The specific  radioactivity of  circulating serum globulins or  antibodies following 
the  intravenous injection of  S~5-1abelled amino acids increases rapidly during the 
first few hours, reaching maximum or near maximum values within 5 to 7 hours (7). 
Similar  observations have  been  made  using  C14-1abelled amino  acids  (8).  These 
values remain relatively constant during the rest of  the first 24 hours, after which 
the specific activity fails at a rate which reflects  the turnover of the protein (8, 9). 
Wherever possible in these experiments, bleedings to determine specific  activity of 
antibody were made 24 hours after injection of S  s5 amino acids which assured max- 
imum S  36 activity. The rapid appearance of S  85 amino acids in circulating proteins 
including antibody indicates not  only a  rapid  incorporation of  amino acids  into 
protein but also a  rapid equilibration between protein at the site of synthesis and 
protein in circulation. 
Since antibodies, like other serum proteins, appear to be synthesized de novo from 
amino acids (4, 9), the amount of antibody synthesis occurring within the first few 
hours after injection  of labelled amino acids will be proportional to the specific activity 
of the antibody isolated subsequently. Thus, rabbits were given antigen, later were 
injected with a  standard dose  of  SSS-labelled amino adds,  and subsequently were 
bled and the specific activity of antibody and non-antibody  globulin was determined. 
Appropriate time intervals between injections of  antigen and S  ss  amino acids  af- 
forded a measure of antibody synthesis throughout the immune response. 
First Response.--Each of 40 white male rabbits weighing between 2.2 and 2.6 kg. received 
a single intravenous injection of 100 rag. bovine gamma globulin (BGG), Armour and Co. 
lot No. C904. The sera of all rabbits were tested for BGG by ring test with high titre anti- 
BGG 7, 8, and 9 days after injection of BGG, and all rabbits were bled for determination of 
maximum serum antibody concentration  3 days  after  the elimination of detectable  circu- 
lating antigen. Serum antibody concentration was measured by ability of the sera to precip- 
itate IzSZ-labelled  BGG  (I*BGG)  (10) and also by quantitative precipitin  determinations 
(11). Eleven rabbits having serum antibody concentrations more than two standard devia- 
tions from the mean of the group were not used for the present calculations since we were 
trying to observe typical primary responses. 
In addition to the BGG, each rabbit received a single i.v. injection of S~-labelled amino 
acids. These labelled amino acids were prepared by Abbott Laboratories and consisted of an 
acid hydrolysate of S  s5 containing yeast to which was added unlabelled tryptophane  to re- 
place that lost by hydrolysis. The radioactivity injected per rabbit in this experiment varied 
from 0.6 to 0.9 mc. and all calculations have been corrected to a standard injection of 0.9 
mc./rabbit. The schedule of S  ~  injections in relation to the injection of BGG is shown on 
Table I. Two rabbits received S  ~  1 day before BGG, two received S  ~ simultaneously with 
BGG and the rest received S  s5 at different intervals after BGG. 
Those rabbits injected with S  ~  amino acids during the first 9 days after BGG were ex- 
sanguinated  10 days after  BGG, at the time of maximum serum antibody concentration. 
Those rabbits receiving S  s5 10 or more days after BGG were exsanguinated 24 hours after 
injection of S  ~.  Sera from ail exsanguination bleedings were analyzed  for #g.  anti-BGG 
N/ml., S~/#g. anti-BGG N, and SSS//zg. non-antibody  globulin N. Prior to these determina- 
tions the sera were decomplemented by adding 100 #g. N  of a preformed specific Ea-anti- 
Ea precipitate  per ml. of serum  (12). The serum-precipitate  mixtures were incubated  at TABLE  I 
P~m~yr~ponse 
S  s5 injection  Maximum serum  S'5 counts//~g.  S  si eounts/lgg.  Antibody 
Rabbit No.  timebefore  antibody  globulin  N  antibody N  SS6/ml.  * 
or after BGG 
24-31 
24-32 
22-13 
22-14 
22-15 
22-16 
22-17 
22-19 
22-20 
22-23 
22-24 
24-21 
24-23 
22-26 
22-27 
22-28 
22-29 
22-30 
22-33 
22-36 
26-25 
22-32 
22-34 
24-29 
26-28 
26-36 
22-31 
24-25 
2641 
days 
--1 
--1 
10 
10 
10 
12 
12 
12 
12 
12 
15 
15 
16 
I.~.N/ml. 
38.3 
50.6 
62.0 
28.5 
49.3 
95.8 
56.4 
54.5 
61.2 
47.1 
51.7 
70.2 
40.4 
56.2 
62.5 
28.6 
52.0 
30.8 
39.2 
73.3 
42.0 
29.9 
108.0 
29.2 
59.5 
55.0 
41.8 
82.5 
84.7 
10.4 
9.6 
10.82 
11.8 
17.6 
13.5 
21.4 
22.7 
26.6 
35.4 
19.7 
26.6 
25.7 
28.2 
28.6 
30.0 
29.4 
19.7 
32.1 
26.2 
23.6 
26.0 
29.4 
38.8 
48.3 
26.2 
24.2 
24.9 
44.4 
12.1 
9.5 
12.,5 
10.7 
20.0 
16.2 
27.6 
23.8 
25.1 
71.4 
30.0 
61.6 
68.4 
60.0 
34.8 
68.0 
60.6 
36.7 
13.7 
24.8 
46.8 
16.1 
16.2 
7.4 
18.6 
5.5 
6.2 
4.6 
6.8 
1160.0 
989.6 
1155.3 
906.8 
1136.4 
1200.0 
1290.0 
1048.4 
943.6 
2017.0 
1322.8 
2315.8 
2661.5 
2127.6 
1216.8 
2266.7 
2061.0 
1862.9 
196.0 
359.0 
1716.0 
335.0 
249.0 
90.0 
210.0 
142.0 
48.0 
76.4 
24.6 
* S  ~6 counts/p,g, antibody N  X/~g. antibody N/ml. 
average maximum serum antibody N/ml. 
X  individual maximum serum antibody N/ml." 
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37°C. for 30 minutes and then placed in the icebox at 0-3°C. for 24 to 48 hours. In the early 
stage of this study some sera were decomplemented by heating at 56%. for 1 hour; but this 
procedure was discontinued because it increased the time necessary for complete precipita- 
tion of antigen and antibody in some sera. After sera were decomplemented, they were clar- 
ified by centrifugation at 4,000 ~.P.,~.  at 0°C.  for several hours. 
Preliminary analyses of the antibody content of the sera were made using I*BGG (10). 
In order to determine the equivalence zone and the exact amount of antibody which was 
precipitated  by  I*BGG,  the  quantitative  immunochemical methods  of  Heidelberger  (11) 
were modified as previously described (13). Then exact amounts of non-labelled BGG were 
added, at or near equivalence, to various volumes of antisera so that 300 to 400/zg. of total 
nitrogen were precipitated. Tubes containing the antibody-antigen mixtures were incubated 
at 37°C. for 30 minutes and then placed in the icebox at 0-3°C. for 4  to 6 days with daily 
mixing.  These  precipitates  were  centrifuged  at  2,200  g.P.M, at  0°C.  for  30  minutes 
and washed twice with chilled 0.15 ~  NaC1.  The 0.15 M NaC1 washings were followed by a 
final washing in distilled water  (pH  7.0).  The washed precipitates were then dissolved in 
2 ml. of 0.01  •  NaOH and duplicate aliquots of 0.5 ml. and 0.3 ml. were removed for deter- 
minations of total nitrogen and S  85 activity respectively. Nitrogen analyses were done by the 
Markham modification of the micro-Kjeldahl technique (14). Antibody nitrogen was calcu- 
lated by subtracting the antigen nitrogen added per 0.5 ml. of dissolved precipitate from the 
total nitrogen content of  the same  aliquot. 
Antibody  S  3s  activity  was  determined  in  the  following manner.  Steel  planchets were 
flamed to  lower  the surface  tension between  the metal and  the solution  (15).  A  ring was 
made with a wax pencil on the outer edge of the horizontal surface to prevent the solution 
from creeping up the sides of the planchets. The 0.3 ml. aliquots of the dissolved precipitates 
were pipetted into the planchets and spread  evenly over the surface. The planchets were 
dried and then counted for a  total of 4,000 counts. All counts were corrected for self-absorp- 
tion and S  ~  decay. Control tubes containing antisera and no BGG were analyzed for non- 
specific precipitation of S  35 activity, and the values obtained were subtracted from the S  ~ 
activity of aliquots of the dissolved precipitates formed with BGG. The specific S  35 activity 
of the antibody (S  3s counts per #g. antibody nitrogen) was then determined by dividing the 
corrected S  3s counts obtained per 0.3 ml. by the respective antibody nitrogen content. 
Globulins were fractionated from sera by 50 per cent saturation at 0°C. with neutralized 
ammonium sulfate.  The antibody was  absorbed from the sera prior to fractionation. The 
precipitates were washed twice with 10 ml. of 50 per cent ammonium sulfate and then dis- 
solved in 10 ml. of 0.15 ~  NaC1.  The dissolved precipitates were dialyzed against running 
tap water for 2 days, and against agitated distilled water for 1 day. These samples were then 
diluted to 20 ml. with 0.02 ~  NaOH which gave a final NaOH concentration of 0.01 ~. Du- 
plicate aliquots of 0.5 and 0.3 ml. were removed for nitrogen and S  35 activity determinations 
respectively.  The  specific  S  35  activity  of  non-antibody  globulin  (S  3s  counts//zg,  globulin 
nitrogen) was calculated by dividing the S  35 counts/0.5 ml. of the globulin solution by the 
globulin nitrogen per 0.5 ml. 
Second Respo~se.--Each of 36 white male rabbits weighing between 2.2 and 2.6 kg.  re- 
ceived i.v.  100 mg.  BGG and was bled 12  days later and serum anti-BGG concentrations 
determined.  The 30  rabbits with more  than 40/zg.  anti-BGG/N ml.  serum were  given a 
second i.v. injection of 100 mg. BGG 5~ weeks after the first. 4 and 5 days after the second 
injection, the sera of all rabbits were tested for the presence of BGG and all were bled for 
determination  of  maximum  serum  antibody  concentration  3  days  after  elimination  of 
antigen, 8 days after injection of BGG. 
These rabbits all received 0.6 to 0.7 mc.  S  35 amino acids with calculations corrected  to 
0.9 mc./rabbit as for the primary response. The schedule of S  35 injections in relation to the 
second injection of BGG is shown in Table II. TABLE  II 
Second response 
S  s5 injection  Maximum  serum  S  s5 counts/#g.  S  sl counts//zg.  Antibody 
Rabbit No.  time  after BGG  antibody  globulin N  antibody  N  SSS/ml.  * 
23-67 
23-68 
23-69 
23-71 
23-72 
23-73 
23-74 
23-76 
27-16 
27-18 
27-22 
23-77 
23-78 
23-79 
23-84 
27-21 
27-24 
27-26 
23-85 
27-23 
27-25 
27-20 
27-27 
27-31 
23-87 
23-89 
23-94 
27-15 
27-29 
27-30 
days 
0 
10 
10 
10 
15 
15 
15 
20 
20 
20 
21 
21 
25 
25 
25 
25 
#g. N/ml. 
291.2 
164.0 
664.8 
225.4 
198.2 
61.5 
222.4 
116.2 
280.0 
118.0 
109.1 
138.7 
89.0 
157.0 
92.1 
84.8 
374.0 
222.8 
351.2 
108.6 
97.0 
275.0 
454.0 
502.0 
120.9 
124.4 
251.0 
450.0 
301.0 
572.0 
14.4 
17.2 
21.1 
21.6 
23.8 
25.3 
19.5 
24.2 
26.0 
27.0 
26.0 
29.0 
17.9 
17.9 
17.9 
17.6 
16.7 
14.3 
22.6 
16.6 
20.5 
20.5 
16.6 
19.9 
20.1 
17.3 
22.1 
19.7 
18.0 
14.1 
12.6 
17.6 
25.8 
25.8 
36.5 
34.8 
46.0 
58.3 
41.2 
54.2 
43.5 
60.7 
37.9 
16.2 
6.1 
3.8 
5.6 
4.8 
4.6 
3.3 
3.6 
2.9 
5.5 
3.1 
4.3 
5.9 
1.8 
3.0 
3.9 
3.0 
3504 
4100 
4892 
4768 
6136 
5504 
9436 
9636 
6184 
8028 
6692 
8372 
84~ 
3620 
1312 
782 
489 
975 
352 
532 
365 
177 
436 
148 
287 
479 
53 
140 
230 
183 
* S  85 counts/Dg, antibody N  X  #g. antibody  N/ml. 
average maximum serum antibody N/ml. 
Xindividual maximum serum antibody N/ml." 
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The rabbits receiving S  ~5 during the first 7 days after BGG were exsanguinated on day 8 
at time of maximum circulating antibody. Those receiving S  a5 after day 8 were exsanguin- 
ated 24 hours after injection of S  3~. Sera from all exsanguinations were analyzed as in the 
primary response. 
Hyperimmune  Response.--Thkteen white male rabbits weighing between 2.2  and 2.6 kg. 
and  demonstrating a  good primary  response were given 5  to 6  courses of BGG injections 
during a  3  month period. Each course consisted of 5 injections totalling 150 mg. of BGG. 
3  months after the beginning of the immunization and  3  weeks after the last injection of 
BGG, ten of these rabbits received 100 mg. BGG intravenously. Tests for circulating BGG 
TABLE III 
Hyperimmune  response 
S  s~ injection  Maximum  serum  S  s6 eounts/~g.  S  s~ counts//~g.  Antibody 
Rabbit No.  time after BOG  antibody  globulin N  antibody  N  SSVml.  * 
26.63 
26-64 
26.78 
26-79 
26-67 
26-68 
26-69 
26-70 
26-71 
26-76 
days 
5 
5 
10 
10 
20 
20 
20 
30 
30 
30 
I~g. N/mL 
1044 
1128 
511 
774 
1592 
934 
1454 
954 
988 
1351 
27.4 
23.9 
19.0 
21.8 
21.0 
31.4 
18.4 
20.0 
16.9 
20.7 
40.3 
37.4 
10.5 
14.0 
9.4 
11.9 
8.6 
6.8 
6.1 
6.9 
29400 
31200 
5029 
6475 
2168 
3~1 
4909 
2011 
1964 
1377 
average S  8~ counts//~g, globulin N 
* S ~ counts/#g, antibodyN X/~g. antibody N/ml. X  individual S  a~ counts/#g, globulin N 
average maximum serum antibody N/ml.. 
X  individual maximum serum antibody N/ml. 
were made 4 and 5 days after injection and all rabbits were bled for determination of maxi- 
mum serum antibody concentration 3  days after elimination of antigen, 8 days after injec- 
tion of BGG. 
The schedule of S  ~5 amino acid injections in relation to injection of BGG is given in Table 
III. The rabbits receiving S  35 on day 5 were exsanguinated on day 8; all others were exsan- 
guinated 24 hours after injection of S  35. Sera from exsanguinations were analyzed as in the 
primary response. 
RESULTS 
All  observations  are  presented  on  the  accompanying  tables  and  figures. 
The incorporation  of S 36 into antibody expressed as antibody  $85/ml.  serum is 
considered  to  be  proportional  to  the  rate  of  antibody  synthesis  at  the  time 
of S ~5 injection.  Thus,  these  antibody  S85/ml.  figures express  relative rotes  of F. ]. DIXON, P. H. ~AAUI%ER, W. O. WEIGLE, ~I. p. DEICH3KILLER  431 
antibody synthesis at  different times throughout the  immune response.  In 
expressing  S  85 incorporated into antibody as antibody $35/ml. serum certain 
experimental variations are eliminated. In this calculation the amount of S  .5 
incorporated into the antibody in 1 ml. of serum of the terminal bleeding  is 
multiplied by 
average S3S//~g. globulin 
individual  $85//~g. globulin 
and also by 
average maximum serum antibody concentration  Using  the individual 
individual  maximum  serum  antibody concentration" 
rabbit's $35/~g. non-antibody globulin in the denominator corrects for individ- 
ual variations in the amino acid pools in which the injected S  36 was diluted. If 
the amino acid pool of an animal was small at the time of injection,  the S  86 
specific activity of the pool would be high and both antibody and globulin 
would be heavily labelled. If the pool was large, both proteins would be lightly 
labelled. Thus, dividing the specific activity of antibody by the specific activ- 
ity of the non-antibody globulin eliminated this variable.  A similar correction 
was used by Fineberg  and  Greenberg  in their study of the incorporation of 
labelled amino acids into ferritin (16). In this case the specific activity of the 
ferritin was compared  to the specific activity of the liver proteins.  Dividing 
the antibody S  35 by the non-antibody globulin S  ss also corrects for non-immune 
catabolism of antibody between time of injection of S  35 and final bleeding. Since 
antibody and non-antibody globulin are normally turned over at the same rate, 
the loss of S  ~5 from the two should be comparable.  This correction is unimpor- 
tant for those rabbits receiving S  85 after elimination of antigen when they were 
bled within 24 hours of S  8s injection, but for those  rabbits injected early in the 
response  with a  considerable  delay before  bleeding  this correction  is sizable. 
Using the maximum serum antibody concentration for each rabbit in the cal- 
culations serves to eliminate individual variations in magnitude of the immune 
response as a source of error. If the amount of antibody formed was great, the 
antibody $35/ml. would be high,  but dividing by the individual's maximum 
serum  antibody concentration  would  compensate  for this.  If the  antibody 
response were below average,  dividing by the serum  antibody concentration 
would offset the low antibody S  s5 value. 
The most meaningful part of these results deals with the decline of antibody 
synthesis which begins about the time of elimination of detectable circulating 
antigen in  each  response.  Mter  the  elimination of circulating antigen,  the 
interval between injection of S  8~ and the final bleeding was brief, usually 1 day, 
so that there is little or no experimental error due to catabolism of antibody or 
reincorporation of S  35. In the primary response, the maximum rate of synthesis 432  RATES  OF  ANTIBODY  SYNTHESIS 
appears to be reached between 6 and 8 days after injection of antigen (Fig. 1). 
During the decline there is considerable scatter of points, but the straight line 
of best fit would indicate a rate of decline of antibody synthesis with a half-life 
of approximately 1.3 days. Antibody synthesis declines within 7 to 8 days to a 
level approximately 1 per cent of the maximum. Whether or not these points 
are best characterized by a  straight line cannot be determined certainly from 
these data but it does not seem unlikely that such may be the case. 
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FIG. 1 
FiGs.  1 to 3.  S  ~ incorporation into antibody is expressed as S  85 counts/minute present in 
the antibody in 1 ml. serum in each response. The S  85 value is plotted on a log scale accord- 
ing to the day of S  35 administration. Thus, each point indicates the relative rate of antibody 
synthesis occurring on the day of S  85 administration. 
In the  second response  the  maximum rate  of antibody synthesis is  found 
between 4  and 6 days after injection of antigen,  and  the  decline  of antibody 
synthesis appears to have two distinct phases (Fig. 2). The first rapid rate of 
decline is  similar to that seen in the primary response but this  steep decline 
changes at about the  time antibody synthesis falls to 8  to 9 per cent of the 
maximum and thereafter the decline is much slower.  There is considerable scat- 
ter in the day 20 and 25 observations making a precise estimate of this second 
rate of decline difficult. 
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antibody synthesis would coincide  approximately with  the  disappearance  of 
antigen and that the change in rates of decline  would occur about day 10 as 
was seen in the second response. The decline  of antibody synthesis in the hy- 
perimmune response also has two distinct phases. The initial rapid decline with 
a 2-day half-life stops at or before the time antibody synthesis falls to approxi- 
mately 20 per cent of the maximum rate. The second rate of decline has a half- 
life of about 12 days. If the initial observed decline in this response is resolved 
into two components by extrapolating the decline  with a half-life  of 12 days, 
the initial rapid component would be virtually the same as the initial decline in 
the first and second responses. 
The observations made prior to the elimination of circulating antigen in the 
first and second responses are subject to several inherent errors and are, there- 
fore, of limited value. First,  antibody formed while  considerable amounts of 
antigen are present may combine with the antigen and be rapidly catabolized 
(17),  and, therefore, not available for analysis at the time of bleeding 3 days 
after disappearance of antigen. This factor would tend to make the early ob- 
servations falsely low. Second,  when S  35 is injected early in the response, with 
the turnover of the initially labelled proteins, it may become available for rein- 
corporation into  antibody prior to the antibody bleeding.  This would result 
in reincorporation  of S  35 into antibody after the period of initial uptake and 
make the values falsely high. 
In the primary response it would appear that the reincorporation factor is 
sizable,  since  the S  Ss content of antibody obtained 10 days after injection of 
antigen is considerable even when the S  35 was given 1 day prior to the antigen. 
A specific labelling  of nearly ~  of the maximum found in the primary response 
resulted from this reincorporation.  There is no detectable uptake of S  85 into 
antibody above this reincorporation level when S  35 is given during the first 4 
days after antigen. In the second response,  there appears to be an increase in 
S  a5 incorporation into antibody with time after injection of antigen. The day 0 
value again probably primarily reflects reincorporation. 
The  amounts  of S  35 incorporated/~g,  antibody N  in  the  three  responses 
were very similar since antibody synthesis in each instance did not significantly 
increase the total protein synthesis. Since serum protein synthesis represents 
only a small part of total protein synthesis it would not be expected that even 
large  antibody responses would make  appreciable  increases in  total  protein 
synthesis. On the basis of the present data, it appears that on the day of maxi- 
mum antibody synthesis the approximate ratio of serum globulin production 
to specific antibody production was as follows: primary response,  30:1; second 
response,  8:1; and hyperlmmune response,  2:1. Looked at another way, at the 
time of maximum rate of antibody synthesis, the per cent of total S  3s injected 
which was incorporated into antibody was as follows: primary, 0.1 per cent; 
second, 0.4 per cent; and hyperimmune, 1.5 per cent. ]~. ~. DIXON, P. H. MAURER,  W. O. V~EIGLE, K~. P. DEICHM/LLER  43~ 
DISCUSSION 
The finding  of a single rapid rate of decline of antibody synthesis in the pri- 
mary response and a similar,  initial rapid rate of decline  followed by a slower 
rate in the second and hyperlmmune responses is not unexpected in the light 
of estimates of rates of antibody synthesis based on levels of circulating anti- 
body alone.  However, the more precise definition  of these rates of decline and 
their duration throw light on several aspects of the antibody response. First, 
the fact that  in all three responses the rate  of antibody synthesis begins to 
decline  rapidly after the elimination of detectable circulating antigen suggests 
that the circulating antigen plays a major role in stimulating antibody synthe- 
sis. Circulating antigen may provide a source of continuing antigenic stimula- 
tion to antibody producing cells. Such a concept would be in accord with the 
present  observations.  Second,  the  rates  of initial  rapid  decline  of antibody 
synthesis are approximately the same in the three responses,  suggesting that 
they reflect the loss of a substance or process of fundamental importance in all 
three situations. Third,  there is a relatively persistent source of antibody pro- 
duction which appears after repeated stimulation and increases  in proportion 
to the number of repeated stimuli. 
It may be worthwhile to review the conflicting  reports on the persistence of 
BGG in rabbits in the  light of the observed rates of antibody synthesis. Using 
1131 tracer  techniques  (2),  fluorescent antibody techniques  (18),  or ordinary 
precipitin tests on serum or tissue extracts, neither BGG nor human gamma 
globulin has been found to persist in significant  amounts in the blood or tissues 
of rabbits after the appearance of circulating antibody, 7 days after the initial 
injection of antigen  and 4  to 5  days after a  secondary injection.  However, 
studies based on soluble antigen-antibody complexes  (19), S85-1abelled  antigens 
(20)  and mouse anaphylaxis tests of organ extracts  (21),  have indicated the 
persistence of BGG in rabbits for many weeks. The rapid decline of antibody 
synthesis after the 7th or 8th day of the primary response and 5th or 6th day 
of secondary response would seem to indicate the loss of the principal antigenic 
stimulus, in agreement with the former findings. 
While  the  present  observations on  antibody synthesis cannot  answer the 
question of persistence of antigen  directly, they do indicate  the duration  of 
effective antigenic stimulation and impose definite conditions on any persisting 
antigen. If, in the primary response, BGG or some recognizable  fraction thereof 
persisted in rabbits after the appearance of circulating antibody, the present 
observations would ascribe little antigenicity to it. Certainly there is no parallel 
between the rapid decline  of antibody synthesis in the primary response and 
the reported long persistence of BGG. If it is assumed that BGG in an active 
antigenic form persists in rabbits for several weeks after its primary injection, 
one must then postulate that there is a mechanism for abruptly terminating 
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antibody formation may result from overdoses of antigen (22),  there is no evi- 
dence  that effective doses of antigens which  are  known  to  persist  for  long 
periods, such as pneumococcal polysaccharides, lose their ability to stimulate 
antibody formation with time (23).  In addition, the persistent antibody syn- 
thesis of the second and hyperimmune responses cannot be correlated with an 
observed increased retention of BGG after repeated injections (2). Even those 
techniques showing persistence of antigens  in  the  host  after  primary injec- 
tion  indicate  less  retention  of  antigen  after  repeated  stimulation  (24,  25). 
If the studies based on antigen-antibody complexes, S85-1abelled antigens, and 
mouse anaphylaxis do detect persisting BGG or some of its products which 
escape  the 1131 tracer and fluorescent antibody techniques, it might be more 
desirable  to  consider this material as merely foreign  rather  than  antigenic, 
especially in the primary response. Until the above measures of persisting BGG 
can be  correlated with observed rates of antibody synthesis  in primary and 
secondary responses they must be accepted with considerable reservation. 
The initial rate of decline of antibody synthesis has a  half-life of approxi- 
mately 1.3 days in the first and second responses and also in the hyperimmune 
response if the observed 2 day half-life is corrected to eliminate the slow com- 
ponent. The significance of this rate  of decline is not apparent, but it could 
reflect several things: first, it could parallel the loss of antigenic material; sec- 
ond, it could reflect the loss of a synthetic process,  such as an adaptive enzyme 
(26),  or inducer, in the absence of antigenic stimulation; or, third, it could be 
dependent upon the loss of a short lived cell type involved in antibody produc- 
tion. These alternatives are not mutually exclusive and their roles, if any, in 
the decline cannot be determined on the basis of the present observations. 
The second slow phase of decline of antibody synthesis which increases in 
importance with repeated antigenic stimulation suggests a more lasting modifi- 
cation or adaptation of globulin synthesis. It could reflect the rate of loss of a 
different, more permanent cell type involved  in the antibody response  after 
repeated stimuli or the loss of an adapted globulin synthesizing mechanism. 
In discussing the rates of hemolysin production in  rabbits,  Taliaferro  and 
Taliaferro postulated that the initial, short lived, rapid synthesis took place in 
the spleen and the prolonged synthesis occurred in non-splenic sites (1).  This 
postulation was based on observations of hemolysin production in intact and 
splenectomized  rabbits. However, in contrast to our  findings  there was  no  evidence 
that the  prolonged non-splenic hemolysin synthesis increased  with repeated 
immunization (27). It is likely that the sites and nature of the persistent anti- 
body synthesis in response to foreign red  cells and foreign serum proteins are 
puite different, probably because of differences in physical and chemical char- 
acteristics of the antigens. 
Our observations on the early part of these responses are difficult to inter- 
pret. The lack of evidence of incorporation of S  ~5 into antibody during the first ~. J. DIXOI~,  P. H. MAUEEE,  W. O. WEIGLE,  M. P. DEICHMILLEE  437 
4 days of the primary response may reflect an initial induction period during 
which little  antibody is  formed.  In  the  secondary response,  however,  there 
appears to be a steady rise in the rate of antibody beginning with the injection 
of antigen.  The early part of the curve in the second response resembles the 
plot of Green and Anker's results (4). However, our early values, and perhaps 
those of Green and Anker, are probably much too high.  A considerable part of 
the S  35 found in antibody following S  35 injection early in the secondary response 
is probably the result of reincorporation  as demonstrated in the primary re- 
sponse.  Our  observations  on  the  second  response  do  not  agree  completely 
either with the work of Green and Anker who concluded that, of the antibody 
present 6 days after the second injection of antigen, 31 per cent was formed in 
the first 60 hours, before the appearance of circulating antibody; or with that  of 
Taliaferro  and  Talmage  (5)  who found virtually no incorporation  of amino 
acid into antibody during the first 3 days of the secondary response. If it is 
assumed that the day 0 S  3~ value of the secondary response is caused by rein- 
corporation and this value is subtracted from the other early second response 
observations, the increase of antibody synthesis would be nearly logarithmic 
beginning at a very low level. A logarithmic increase  of antibody synthesis in 
the secondary response of rabbits has been postulated by Burner and Fenner 
(26). In such a situation the amount of antibody synthesized in the first 3 days 
would amount to only a few per cent of the total synthesized in the first 6 days, 
which would be close to those values obtained by Taliaferro and Talmage. 
The data on the specific activity of antibody and other serum proteins would 
corroborate at least for antibody, the conclusions  of others working with bac- 
terial  (28, 29) and mammalian  (16, 30) systems; namely that protein biosyn- 
thesis is de novo from amino acids.  Antibody synthesis probably involves the 
induced formation (in the presence of antigen)  of new gamma globulin rather 
than  the  conversion of a  preexisting  serum globulin.  This  system resembles 
closely the induced synthesis of proteins as studied by Spiegelman  and Monod 
and their coworkers. 
SUMMARY 
Determinations of the rates of antibody synthesis during first, second, and 
hyperimmune  responses  to  bovine gamma  globulin  using S3S-labelle aminod 
acids indicate the following: 
1. In aU three responses the rate of antibody synthesis increases while anti- 
gen is circulating  and then begins to decline  rapidly after elimination  of de- 
tectable circulating antigen. 
2. The initial  rates of decline  of antibody synthesis are approximately the 
same for all three responses. 
3. There is a relatively persistent source of antibody production which ap- 438  RATES O:F ANTIBODY SYNTHESIS 
pears after repeated stimulation  and increases in proportion to the number of 
repeated stimuli. 
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